Benchling Stock Price, Valuation & IPO
Private company — Benchling is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.
Status source: AXEVIL investment team
$6.33 per share (AXEVIL consensus estimate)
Source: AXEVIL consensus of recent secondary transactions · as of 27 October 2026
Last round valuation: $6.1B
Source: F, November 2021, post-money
Total raised: ~$412M
Data last updated: 27 October 2026
About Benchling
Cloud platform for biotech R&D: an electronic lab notebook and data management for scientists. Its latest primary round was a $100M Series F in November 2021 at a $6.1B valuation; there have been no new primary rounds since, and secondary-market shares trade notably lower (around $3.9B). Annual recurring revenue is about $200M.
Benchling is the cloud operating system for the biotech laboratory. Founded in 2012 in San Francisco. In place of paper notebooks and scattered spreadsheets, the company provides a single environment where scientists run experiments, track samples, design molecules, and analyze results. The key innovation is not the electronic notebook itself but the unified data structure beneath it: every sample, genetic construct, and measurement lands in a shared registry, so one scientist's result is immediately usable in another's calculations and for training models, rather than sitting as text in someone else's file. Valued at $6.1B in a $100M Series F (November 2021); roughly $412M raised in total.
- Sector: Healthcare & Biotech
- Headquarters: San Francisco, USA
- Founded: 2012
Key highlights
- The secondary-market share price is a third below the last primary round while the business has grown. The November 2021 Series F priced at $32.7 per share; today access is available at $21 — 36% cheaper.
- Siemens has just set a price for this market. In April 2025 the corporation bought direct competitor Dotmatics for $5.1B on more than $300M of revenue — 17 times annual revenue — and stated that life-sciences software spending would double over five years.
- Laboratory data has become fuel for models, and Benchling owns it. The value of artificial intelligence in biology is limited not by the models, which are open, but by structured experimental results, which almost nobody holds in machine-readable form.
- The 2026 product cycle is unfolding right now. In May alone it shipped Model Hub, an antibody format designer, one-click materials ordering, and Benchling Automation, following connectors to external data sources in April.
- The leadership team is assembled for public-company status. Finance has been run since 2022 by Ron Gill, former CFO of NetSuite.
Funding rounds
| Date | Round | Price / share | Post-money valuation |
|---|---|---|---|
| 18 November 2021 | F | $32.70 | $6.1B |
| 14 April 2021 | E | $23.22 | $4B |
| 28 May 2020 | D | $5.56 | $850M |
| 24 July 2019 | C | $2.85 | $375M |
| 14 June 2018 | B | $0.64 | $78M |
| 24 October 2016 | A | $0.45 | $38M |
| 15 April 2015 | Seed | $0.28 | $18M |
Latest news
Frequently asked questions
How can I buy Benchling stock before the IPO?
Not on a public exchange — Benchling is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.
What is the Benchling stock price?
A private company has no single official share price. AXEVIL's consensus estimate is $6.33 per share as of 27 October 2026. Its most recent round implied a post-money valuation of $6.1B (November 2021).
What is Benchling's valuation (net worth)?
Benchling's most recent funding round valued the company at $6.1B post-money (November 2021) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.
When will Benchling IPO?
No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.
Is Benchling publicly traded?
No. Benchling is a private company and its shares are not listed on any public exchange.
Does Benchling have a stock symbol?
No. Benchling has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.
Similar companies
- Chai Discovery — Healthcare & Biotech
- Altos Labs — Healthcare & Biotech
- Neuralink — Healthcare & Biotech
- Nuro — Transportation
- Tenstorrent — Semiconductors
- Valar Atomics — Energy
Risk disclosure
Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.